Blue Door Asset Management LLC Has $10.54 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Blue Door Asset Management LLC lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 4.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 500,035 shares of the company's stock after buying an additional 23,400 shares during the period. Avantor comprises about 3.9% of Blue Door Asset Management LLC's portfolio, making the stock its 7th biggest holding. Blue Door Asset Management LLC owned about 0.07% of Avantor worth $10,536,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Dodge & Cox increased its holdings in shares of Avantor by 44.9% during the fourth quarter. Dodge & Cox now owns 99,145,770 shares of the company's stock worth $2,089,001,000 after buying an additional 30,727,673 shares in the last quarter. Vanguard Group Inc. increased its holdings in Avantor by 1.9% in the 4th quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company's stock worth $1,347,843,000 after purchasing an additional 1,211,418 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its position in Avantor by 41.4% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company's stock valued at $643,227,000 after purchasing an additional 8,936,879 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Avantor by 0.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 21,037,089 shares of the company's stock valued at $443,251,000 after purchasing an additional 112,644 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Avantor by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 11,232,329 shares of the company's stock worth $236,227,000 after purchasing an additional 81,541 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Trading Up 2.3 %

Shares of AVTR stock opened at $15.30 on Wednesday. The company has a market cap of $10.43 billion, a P/E ratio of 14.71, a PEG ratio of 1.55 and a beta of 1.24. Avantor, Inc. has a fifty-two week low of $13.80 and a fifty-two week high of $28.00. The stock has a 50 day simple moving average of $16.20 and a two-hundred day simple moving average of $19.97. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the firm posted $0.22 EPS. Research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity

In other news, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AVTR. Raymond James reiterated an "outperform" rating and issued a $24.00 price objective (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Morgan Stanley cut their price target on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. UBS Group restated a "neutral" rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Citigroup lowered their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Finally, Cowen reiterated a "buy" rating on shares of Avantor in a research report on Tuesday, March 18th. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Avantor presently has an average rating of "Moderate Buy" and a consensus price target of $24.82.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.